DigestRedComo funciona
Red
/
Empresas
Ki
No verificado

Kiromic BioPharma, Inc.

Sobre qué escribimos

FarmacéuticaIndustriaMedicina - VariosOncologíaSalud

12 Comunicados de prensa

Ver todos los comunicados de prensa
18/02/2025
Industria
Biotecnología
Salud
Farmacéutica
Medicina - Varios
Oncología
Kiromic BioPharma Reports Patient 4 in Deltacel-01 Clinical Trial Reaches 10-Month Progression-Free Survival
Fuente
Kiromic BioPharma, Inc.
Editor
Business Wire
1.00
0
21/01/2025
Industria
Salud
Técnica
Medicina - Varios
Oncología
Kiromic BioPharma Reports Tumor Volume Decrease in Two Patients Enrolled in Deltacel-01
Fuente
Kiromic BioPharma, Inc.
Editor
Business Wire
1.00
0
12/12/2024
Salud
Oncología
Medicina - Varios
Industria
Kiromic BioPharma Reports 32% Decrease in Tumor Volume Eight Months Post-Treatment in Fourth Patient Enrolled in Deltacel-01
Fuente
Kiromic BioPharma, Inc.
Editor
Business Wire
1.00
0
03/12/2024
Biotecnología
Farmacéutica
Salud
Oncología
Kiromic BioPharma Announces Settlement of Previously Disclosed SEC Investigation
Fuente
Kiromic BioPharma, Inc.
Editor
Business Wire
1.00
0
08/10/2024
Industria
Oncología
Salud
Sanidad
Medicina - Varios
Farmacéutica
Biotecnología
Kiromic BioPharma Reports Favorable Ongoing Clinical Results From Fourth and Sixth Patients Enrolled in Deltacel-01
Fuente
Kiromic BioPharma, Inc.
Editor
Business Wire
1.00
0
01/10/2024
Industria
Sanidad
Salud
Medicina - Varios
Oncología
Kiromic BioPharma Reports Favorable 10-Month Follow-Up Results for the First Patient Treated in its Deltacel-01 Clinical Trial
Fuente
Kiromic BioPharma, Inc.
Editor
Business Wire
1.00
0
19/09/2024
Industria
Oncología
Salud
Ciencia
Farmacéutica
Biotecnología
Kiromic BioPharma Activates the University of Arizona Cancer Center as the Fifth Clinical Trial Site in the Ongoing Phase 1 Deltacel-01 Trial
Fuente
Kiromic BioPharma, Inc.
Editor
Business Wire
1.00
0
19/09/2024
Industria
Biotecnología
Farmacéutica
Oncología
Sanidad
Salud
Medicina - Varios
Kiromic BioPharma Advances Deltacel-01 Into Expansion Phase Following Safety Monitoring Committee’s Unanimous Recommendation
Fuente
Kiromic BioPharma, Inc.
Editor
Business Wire
1.00
0
14/08/2024
Ciencia
Farmacéutica
Oncología
Técnica
Medicina - Varios
Biotecnología
Higiene alimentaria
Salud
Industria
Kiromic BioPharma’s Deltacel Receives FDA Fast Track Designation
Fuente
Kiromic BioPharma, Inc.
Editor
Business Wire
1.00
0
09/08/2024
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Industria
Kiromic BioPharma Provides Update on Part 1 of the Deltacel-01 Trial
Fuente
Kiromic BioPharma, Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0